CyberArk's subscription revenues surge 66% in Q2 2025, fueled by customer migration, upsells, and multi-solution adoption.
Most of the focus is going to be on preferred shares, but we're also talking baby bonds and one common share. Some investors want upside if rates fall. Others want yield or greater security. One management team decided to pump out some shares below our estimate for book value. Share prices promptly underperformed all peers.
Nebius' Q2 ARR surged to $430 million, exceeding the $372–$403 million forecast and marking 39% sequential growth. Reported revenue of $105.1 million rose 106% quarter-over-quarter and 625% year-over-year, reflecting rapid capacity expansion and high utilization. Active capacity estimated at 50–55 MW implies ARR density of $7.8–$8.6 million per MW in Q2 2025.
NBIS raises 2025 ARR target to $1.1B after Q2 revenue surges 625% on soaring AI infrastructure demand.
Armour Residential's Q2 2025 book value decline and core earnings underperformance were largely as expected, but results lagged stronger agency mREIT peers. Minor book value underperformance and disappointing net spread income contributed to weaker results, with operational expenses also rising more than projected. Despite modest outperformance in July's book value, ARR's risk/performance rating remains at 4, reflecting ongoing concerns versus peers like AGNC and NLY.
I maintain my buy rating on Varonis Systems, as strong ARR growth and SaaS transition progress signal robust underlying fundamentals and future upside. SaaS ARR now comprises 69% of total ARR, with the transition set to complete a year early, accelerating the growth and margin inflection timeline. Improving net revenue retention and larger initial deal sizes confirm customer demand, supporting my view that VRNS' ARR growth could exceed 20%.
ARR offers a tempting 17% yield, but persistent book value erosion and a history of dividend cuts make me cautious. The hedging strategy supports current payouts, yet high leverage and rate/spread sensitivity expose ARR to significant downside risk. I prefer stable, lower-risk income; I need to see Fed rate cuts and book value stabilization before considering ARR for my portfolio.
ARMOUR Residential REIT focuses on agency mortgage-backed securities, with a small exposure to U.S. Treasuries added during H1 2025. ARR's recent underperformance largely stems from losses on derivatives positions, as well as continued common stock issuance. Looking ahead, the company trades at only 4.9x consensus 2026 earnings, with its key net interest spread likely to increase from currently depressed levels of only 0.36%.
Nebius surpassed $310 million in ARR by April and is projected to exit Q2 with ~$372-403 million. A Q2 exit ARR well above $400 million could serve as a key inflection point, signaling outperformance, justifying upward guidance revisions, and accelerating institutional re-rating of the stock. Q2 revenue is expected to double sequentially to $101.2 million, reinforcing momentum toward the $500-$700 million FY guide.
ARR, GSHD and IBP have been added to the Zacks Rank #5 (Strong Sell) List on July 28, 2025.
Armour Residential REIT (NYSE:ARR ) Q2 2025 Earnings Conference Call July 24, 2025 8:00 AM ET Company Participants Desmond E. Macauley - Co-Chief Investment Officer & Head of Risk Management Gordon Mackay Harper - CFO & Secretary Scott Jeffrey Ulm - CEO and Vice Chairman Sergey Losyev - Co-Chief Investment Officer Conference Call Participants Douglas Michael Harter - UBS Investment Bank, Research Division Eric J.
Armour Residential REIT (ARR) came out with quarterly earnings of $0.77 per share, missing the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $1.08 per share a year ago.